SIGNIFICANCE OF THE T(1418) TRANSLOCATION AND BCL-2 GENE DEREGULATION IN NON-HODGKINS-LYMPHOMA

被引：0
|
作者：
MCDONNELL, TJ
机构：
来源：
DIAGNOSTIC ONCOLOGY | 1994年 / 4卷 / 01期
关键词：
BCL-2; ONCOGENE; APOPTOSIS; LYMPHOMA; CHROMOSOMAL TRANSLOCATION;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The bcl-2 proto-oncogene was discovered by cloning the t(14;18)(q32;q21) translocation breakpoint seen in most follicular lymphomas. However, bcl-2 may be highly expressed in the absence of the t(14;18) so that assessment of its prognostic significance must be based on gene expression as well as cytogenetics. The bcl-2 oncogene is unique in its ability to extend cellular viability by overriding programmed cell death without augmenting cellular proliferation. Therapeutic interventions are now being implemented to induce programmed cell death in lymphoid malignancies.
引用
收藏
页码：18 / 21
页数：4
相关论文
共 50 条
  • [1] THE T(1418) CHROMOSOMAL TRANSLOCATION AND BCL-2 PROTEIN EXPRESSION IN HODGKINS-DISEASE
    GUPTA, RK
    LISTER, TA
    BODMER, JG
    LEUKEMIA, 1994, 8 (08) : 1337 - 1341
  • [2] THE BCL-2 ONCOGENE IN HODGKINS-DISEASE ARISING IN THE SETTING OF FOLLICULAR NON-HODGKINS-LYMPHOMA
    LEBRUN, DP
    NGAN, BY
    WEISS, LM
    HUIE, P
    WARNKE, RA
    CLEARY, ML
    BLOOD, 1994, 83 (01) : 223 - 230
  • [3] DETECTION OF SOMATIC MUTATIONS OF THE BCL-2 ONCOGENE IN FOLLICULAR NON-HODGKINS-LYMPHOMA
    PAPPA, V
    WILKES, S
    ROHATINER, AZS
    LISTER, TA
    YOUNG, BD
    BLOOD, 1994, 84 (10) : A444 - A444
  • [4] A MULTIVARIATE STUDY OF NON-HODGKINS-LYMPHOMA INVOLVING PROLIFERATION, APOPTOSIS, BCL-2 AND THE MICROENVIRONMENT
    SHETTY, V
    MUNDLE, S
    SANOY, A
    SANGHVI, R
    LOEW, J
    MARCUS, B
    SHOWEL, J
    GREGORY, S
    RAZA, A
    LEUKEMIA & LYMPHOMA, 1995, 18 (3-4) : 273 - &
  • [5] SEQUENCE PRESERVATION OF THE 3RD EXON OF THE BCL-2 GENE IN NON-HODGKINS-LYMPHOMA - ABSENCE OF SOMATIC HYPERMUTATION
    FARRUGIA, MM
    DUAN, LJ
    REIS, MD
    NGAN, BY
    SAWKA, CA
    BERINSTEIN, NL
    LEUKEMIA, 1995, 9 (04) : 643 - 649
  • [6] MECHANISMS OF LAZ3/BCL6 DEREGULATION IN NON-HODGKINS-LYMPHOMA (NHL)
    BASTARD, C
    DEWEINDT, C
    QUIEF, S
    DALLERY, E
    GALIEGUEZOUITINA, S
    DHOOGHE, MC
    TILLY, H
    KERCKAERT, JP
    BLOOD, 1994, 84 (10) : A440 - A440
  • [7] BCL-2 IMMUNOPEROXIDASE STAINING IN FOLLICULAR LYMPHOMA WITHOUT T(1418)
    GASCOYNE, R
    HORSMAN, D
    LEE, U
    CONNORS, JM
    LABORATORY INVESTIGATION, 1994, 70 (01) : A109 - A109
  • [8] THE BCL-2/JH REARRANGEMENT IS PRESENT IN NON-HODGKINS-LYMPHOMA AND CHRONIC TONSILLITIS, BUT NOT IN HODGKINS LYMPHOMA - A MOLECULAR-GENETIC AND IMMUNOHISTOCHEMICAL INVESTIGATION
    NOLTE, M
    WERNER, M
    SPANN, W
    SCHNABEL, B
    VONWASIELEWSKI, R
    WILKENS, L
    GEORGII, A
    PATHOLOGE, 1993, 14 (06): : 302 - 306
  • [9] GENE AMPLIFICATION IN NON-HODGKINS-LYMPHOMA
    BENYEHUDA, D
    HOULDSWORTH, J
    PARSA, NZ
    CHAGANTI, RSK
    BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (04) : 792 - 797
  • [10] EXPRESSION IN NON-HODGKINS LYMPHOMA OF THE BCL-2 PROTEIN ASSOCIATED WITH THE T(14-18) CHROMOSOMAL TRANSLOCATION
    NGAN, BY
    CHENLEVY, Z
    WEISS, LM
    WARNKE, RA
    CLEARY, ML
    NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (25): : 1638 - 1644
12345